(Q37599548)

21 August 2017

1 reference

title

New therapies for non-muscle-invasive bladder cancer (English)

1 reference

21 August 2017

Edmund Chiong

1

1 reference

PubMed ID

19763584

21 August 2017

Kesavan Esuvaranathan

series ordinal

2

1 reference

21 August 2017

18 September 2009

1 reference

21 August 2017

World Journal of Urology

1 reference

21 August 2017

28

1 reference

21 August 2017

71-78

1 reference

21 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-009-0474-1

21 August 2017

0 references

cites work

Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-009-0474-1

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-009-0474-1

Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects

21 January 2018

1 reference

12 December 2020

AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model

1 reference

12 December 2020

Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.

1 reference

12 December 2020

Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Superficial bladder cancer: progression and recurrence

1 reference

12 December 2020

Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine

1 reference

12 December 2020

Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder.

1 reference

12 December 2020

Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study

1 reference

12 December 2020

Management of BCG failures in superficial bladder cancer: a review

1 reference

12 December 2020

Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy

1 reference

12 December 2020

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

1 reference

12 December 2020

Nonviral cytokine gene therapy on an orthotopic bladder cancer model.

1 reference

12 December 2020

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation

1 reference

12 December 2020

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response

1 reference

12 December 2020

Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2

1 reference

12 December 2020

Combination of BCG and interferon intravesical immunotherapy: an update.

1 reference

12 December 2020

Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy

1 reference

12 December 2020

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

1 reference

12 December 2020

Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma

1 reference

12 December 2020

Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells

1 reference

12 December 2020

Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.

1 reference

12 December 2020

Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens

1 reference

12 December 2020

Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study

1 reference

12 December 2020

Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy

1 reference

12 December 2020

Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.

1 reference

12 December 2020

Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma

1 reference

12 December 2020

Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC).

1 reference

12 December 2020

Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.

1 reference

12 December 2020

Intravesical suramin: a novel agent for the treatment of superficial transitional-cell carcinoma of the bladder.

1 reference

12 December 2020

Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent

1 reference

12 December 2020

A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer

1 reference

12 December 2020

Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

12 December 2020

Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy study

1 reference

12 December 2020

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer

1 reference

12 December 2020

Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin

1 reference

12 December 2020

Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors

1 reference

12 December 2020

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

12 December 2020

Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma

1 reference

12 December 2020

Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies

1 reference

12 December 2020

Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin

1 reference

12 December 2020

Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer

1 reference

12 December 2020

Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium

1 reference

12 December 2020

Intravesical gemcitabine: a phase 1 and pharmacokinetic study

1 reference

12 December 2020

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma

1 reference

12 December 2020

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial

1 reference

12 December 2020

Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion

1 reference

12 December 2020

Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.

1 reference

12 December 2020

Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers

1 reference

12 December 2020

Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin)

1 reference

12 December 2020

Taxol and taxotere in bladder cancer: in vitro activity and urine stability

1 reference

12 December 2020

Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.

1 reference

12 December 2020

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

1 reference

12 December 2020

10.1007/S00345-009-0474-1

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19763584